Figure 1From: Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer Kaplan-Meier estimates of survival among OPSCC patients according to p16 expression. Panels A and B show the benefits in OS and DFS, respectively, in patients with p16-positive OPSCC compared with p16-negative OPSCC (p = 0.04 and 0.05, respectively).Back to article page